Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Lijie Tan is a leading thoracic surgeon whose research has fundamentally advanced the surgical management of esophageal squamous cell carcinoma (ESCC). His primary focus is on comparing and optimizing minimally invasive surgical techniques, with a particular emphasis on robot-assisted esophagectomy. Dr. Tan’s most impactful contribution is his landmark 2021 study comparing robot-assisted minimally invasive esophagectomy (RAMIE) to conventional minimally invasive esophagectomy (MIE), which has garnered 193 citations and provides critical evidence on perioperative and long-term outcomes for ESCC patients. He is also the principal architect behind the multicenter prospective randomized controlled RAMIE trial, detailed in a highly cited 2019 protocol paper (61 citations) that established the rigorous framework for comparing robot-assisted esophagectomy (RAE) with conventional MIE. Through this systematic, evidence-based approach, Dr. Tan has been instrumental in defining the role of robotic surgery in esophageal oncology, helping to shape modern surgical standards and improve patient outcomes in this challenging field.